ONCE - Spark Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $120.96. This is a potential upside of $7.39 (6.51%) from yesterday's end of day stock price of $113.57.

Spark Therapeutics's activity chart (see below) currently has 119 price targets and 84 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 96.22% with an average time for these price targets to be met of 197.24 days.

Most recent stock forecast was given by PHIL NADEAU from TD COWEN on 25-Mar-2019. First documented stock forecast 24-Feb-2015.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 25-Mar-2019

$80

6 years 9 months 16 days ago
(25-Mar-2019)

5/5 (100%)

$23.99 (42.83%)

375

Buy

Since 25-Mar-2019

$74

$-39.57 (-34.84%)

6 years 9 months 16 days ago
(25-Mar-2019)

6/7 (85.71%)

$-39.53 (-34.82%)

203

Hold

Since 27-Feb-2019

$65

$-48.57 (-42.77%)

$65

6 years 10 months 14 days ago
(27-Feb-2019)

5/6 (83.33%)

$-48.4 (-42.68%)

212

Hold

Since 26-Feb-2019

$72

6 years 10 months 15 days ago
(26-Feb-2019)

6/6 (100%)

$16.24 (29.12%)

280

Buy

Since 09-Oct-2018

$70

6 years 10 months 16 days ago
(25-Feb-2019)

1/1 (100%)

$20.66 (41.87%)

139

Show more analysts

Please expand the browser size to see the chart

What is ONCE (Spark Therapeutics) average time for price targets to be met?

On average it took 197.24 days on average for the stock forecasts to be realized with a an average price target met ratio 96.22

Which analyst has the current highest performing score on ONCE (Spark Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on ONCE (Spark Therapeutics)?

Elemer Piros has 6 price targets and 6 ratings on ONCE

Which analyst is the currently most bullish on ONCE (Spark Therapeutics)?

Difei Yang with highest potential upside - $0.43

Which analyst is the currently most reserved on ONCE (Spark Therapeutics)?

David Nierengarten with lowest potential downside - -$73.57

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?